Can preoperatively measured inflammatory markers in total knee arthroplasty be an early indicator for revision?
Are preoperative inflammatory markers an early indication for revision?
DOI:
https://doi.org/10.5281/zenodo.7715474Keywords:
total knee arthroplasty, Systemic immune-inflammatory index, revision, neutrophil-lymphocyte ratioAbstract
Aim: Knee replacement is one of the most commonly performed orthopedic surgeries today. Various prognostic markers are being investigated to reduce the revision rate. In this study, inflammatory markers measured from preoperative blood were evaluated in terms of revision.
Material and Method: 100 patients who underwent Total Knee prosthesis between January 2017 and December 2021 (50 revisions and 50 non-revisions) were included in the study. Systemic immune-inflammatory index (SII), neutrophil-lymphocyte ratio(NLR), lymphocyte-monocyte ratio(LMR) and platelet-lymphocyte ratios(PLR) calculated from the hemograms taken before the first surgery of these patients; were evaluated comparatively between those with and without revision surgery.
Results: The mean age of the patients was 63.98±9.30 (38-80) in patients who underwent revision, and 65.64±9.45 (46-87) in patients who did not undergo revision. There was no significant difference in age and gender distribution between the revised and non-revisioned groups (p>0.05). No significant difference was observed in the number of neutrophils, lymphocytes, and monocytes between the revised and non-revisioned groups (p>0.05). There was no significant difference in SII, NLR, LMR and PLR values between the revised and non-revisioned groups (p>0.05)
Conclusion: SII, NLR, LMR and PLR calculated from the preoperative hemogram taken before total prosthesis surgery, and no significant relationship was found between revision of the knee prosthesis.
Downloads
References
Dawson J, Linsell L, Zondervan K, et al. Epidemiology of hip and knee pain and its impact on overall health status in older adults. Rheumatology (Oxford) 2004;43:497-504
EUMUSC. Musculoskeletal Health in Europe 2011; [Consulted 2014 Jan 08]; Disponível em: http://www.eumusc.net/myUploadData/files/ Musculoskeletal%20Health%20in%20Europe%20Report%20v5.pdf.
Andrianakos AA, Kontelis LK, Karamitsos DG, et al. Prevalence of symptomatic knee, hand, and hip osteoarthritis in Greece. The ESORDIG study. J Rheumatol. 2006;33:2507-13.
Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010;18:476-99.
Peat G, Thomas E, Duncan R, et al. Clinical classification criteria for knee osteoarthritis: performance in the general population and primary care. Ann Rheum Dis. 2006;65:1363-7.
Bozic KJ, Kurtz SM, Lau E, et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res 2010;468(1):45-51.
Miller J. Improved fixation in total hip arthroplasty using L.V.C. surgical technique (brochure). Warsaw, IN: Zimmer; 1980.
Li S, Scuderi G, Furman BD, et al. Assessment of backside wear from the analysis of 55 retrieved tibial inserts. Clin Orthop Relat Res 2002;404:75–82.
Jiranek WA, Machado M, Jasty M, et al. Production of cytoki¬ nes around loosened cemented acetabuler components. J Bo¬ ne Joint Surg 1993, 75-A(6):863-79.
Chiba J, Rubash HE, Rim KJ, et al.: The characterization of cytokines in the interface tissue obtained from failed cement¬ less total hip arthroplasty with and without femoral osteolysis . Clin Orthop 1994, 300:304-12.
Shanbly AS, Jacobs JJ, Black J, et al. Cellu¬ lar mediators secreted by interfacial membranes obtained at revision total hip arthroplasty. J Arthroplasty 1995, 10(4):498-506.
Spector TD, Hart DJ, Nandra D, et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997;40:723e7.
Livshits G, Zhai G, Hart DJ, et al. Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: the Chingford study. Arthritis Rheum 2009;60:2037e45.
H. Luo, L. He, G. Zhang, et al. Normal Reference Intervals of Neutrophil-To-Lymphocyte Ratio, Platelet-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Systemic Immune Inflammation Index in Healthy Adults: a Large Multi-Center Study from Western China, Clinical laboratory. 65(2019)10.7754/Clin.Lab.2018.180715.
Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014 Dec 1;20(23):6212-22. doi: 10.1158/1078-0432.CCR-14-0442. Epub 2014 Sep 30. PMID: 25271081.
Geng Y, Shao Y, Zhu D, et al. Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis. Sci Rep. 2016 Dec 21;6:39482. doi: 10.1038/srep39482. PMID: 28000729; PMCID: PMC5175190.
Hong, X. et al. Systemic Immune-inflammation Index, Based on Platelet Counts and Neutrophil-Lymphocyte Ratio, Is Useful for Predicting Prognosis in Small Cell Lung Cancer. Tohoku J Exp Med 236, 297–304 (2015).
Peng, Y., Huang, W., Shi, Z., C et al. (2020). Positive association between Systemic Immune-Inflammatory Index and mortality of Cardiogenic shock. Clinica Chimica Acta. doi:10.1016/j.cca.2020.09.022
Kim, J.-W., Jung, J.-Y., Suh, C.-H., & Kim, H.-A. (2020). Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still’s disease. Clinical Rheumatology. doi:10.1007/s10067-020-05266-2
Wu, J., Yan, L., & Chai, K. (2021). Systemic immune‐inflammation index is associated with disease activity in patients with ankylosing spondylitis. Journal of Clinical Laboratory Analysis, 35(9). doi:10.1002/jcla.23964
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Chronicles of Precision Medical Researchers
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
